Norman Ruchholtz
Amministratore Delegato presso Cantourage GmbH
Posizioni attive di Norman Ruchholtz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Cantourage GmbH
 Cantourage GmbH Pharmaceuticals: MajorHealth Technology Part of Cantourage Group SE, Cantourage GmbH is a leading European medical cannabis company based in Kleinmachnow, Germany. The German company focuses on long-term collaborations and strategic partnerships to provide patients with an unprecedented selection of the highest quality cannabis medicines at affordable prices. Cantourage offers products in all relevant market segments, including dried flowers, extracts, dronabinol, and pharma-grade cannabidiol. Cantourage's unique fast track access platform enables producers from across the world to become part of the rapidly growing European medical cannabis market, providing medical cannabis-related products to millions of people in Europe. The company was founded in 2019 by Florian Holzapfel, Patrick Hoffmann, and Norman Ruchholtz, who has been the CEO since 2019. | Amministratore Delegato | 01/01/2019 | - |
| Fondatore | 01/01/2019 | - |
Storia della carriera di Norman Ruchholtz
Precedenti posizioni note di Norman Ruchholtz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CANTOURAGE GROUP SE | Fondatore | 01/01/2019 | - |
Statistiche
Distribuzione geografica
| Germania | 3 |
Posizioni
| Founder | 2 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 2 |
| Process Industries | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CANTOURAGE GROUP SE | Process Industries |
| Aziende private | 1 |
|---|---|
Cantourage GmbH
Cantourage GmbH Pharmaceuticals: MajorHealth Technology Part of Cantourage Group SE, Cantourage GmbH is a leading European medical cannabis company based in Kleinmachnow, Germany. The German company focuses on long-term collaborations and strategic partnerships to provide patients with an unprecedented selection of the highest quality cannabis medicines at affordable prices. Cantourage offers products in all relevant market segments, including dried flowers, extracts, dronabinol, and pharma-grade cannabidiol. Cantourage's unique fast track access platform enables producers from across the world to become part of the rapidly growing European medical cannabis market, providing medical cannabis-related products to millions of people in Europe. The company was founded in 2019 by Florian Holzapfel, Patrick Hoffmann, and Norman Ruchholtz, who has been the CEO since 2019. | Health Technology |
- Borsa valori
- Insiders
- Norman Ruchholtz
- Esperienza
